Document is current
Any future updates will be listed below
-
Authors
Glück, Christian
Widmeier, Eugen
Maier, Sven
Staudacher, Dawid L.
Wengenmayer, Tobias
Supady, Alexander https://orcid.org/0000-0003-4056-3652
-
Funding
Funding for this research was provided by:
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 1 October 2024
Revised: 1 October 2024
Accepted: 30 December 2024
First Online: 31 January 2025
Declarations
:
: All authors have completed the ICMJE form (available upon request from the corresponding author). D.L. Staudacher received honoraria for lecturing Abiomed, AstraZeneca, Getinge, Medtronic, Dahlhausen and Orion Pharma, all of which are unrelated to this manuscript. T. Wengenmayer reports lecture fees from Getinge and Resuscitec. A. Supady reports research grants and lecture fees from CytoSorbents, lecture fees from Getinge, Resuscitec, AstraZeneca and Abiomed and travel support and consulting fees from ARTCLINE, all outside the submitted work. A. Supady is member of the scientific committee of EuroELSO. C. Glück, E. Widmeier and S. Maier declare that they have no competing interests.
: Data collection was approved by the institutional ethics committee of the University of Freiburg (EK 151/14); due to the retrospective and observational nature of the study, the need for informed consent was waived.
